Ultragenyx Pharmaceutical (RARE) Sɔɔtɔ Fɔrɛkɛst
Nɔnyɔ nyɛ$14.49Nɔɔ 25 Gbo 2026 19:59 UTC
Nyuɛ-1.90%
AI forecast: RARE
AI bɔɔ target price fɔ trading day tɛnɛ, week ɛnɛ ɛkpɔ month ɛnɛ ɛkɛ. Change bɔɔ latest price lɛ. Statistical estimates lɛ, not investment advice.
Nɔnyɔ ɔhɛ 6 dɛnɛ a akɛ
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nɔ nyɛmɛ nyɛ nyɛmɛ
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumƐŋɛ Nɛ Kɔmpɔni A
Ultragenyx Pharmaceutical Inc. provides biotechnology services. The company develops therapeutic agents and sialic acids for the treatment of metabolic disorders, myopathies, glucuronidase-related conditions, and rare genetic diseases. The company operates in the United States.
